Metropolitan Life Insurance Company (MetLife)’s Pediatrix Medical MD Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,982	Closed	-$50K	–	1252
2024 Q1	$50K	Hold	4,982	–	–	﹤0.01%	1404
2023 Q4	$46.3K	Hold	4,982	–	–	﹤0.01%	1490
2023 Q3	$63.3K	Buy	4,982 +490	+11%	+$6.72K	﹤0.01%	1261
2023 Q2	$63.8K	Buy	4,492 +382	+9%	+$5.36K	﹤0.01%	1282
2023 Q1	$61.3K	Sell	4,110 -986	-19%	-$14.9K	﹤0.01%	1280
2022 Q4	$75.7K	Hold	5,096	–	–	﹤0.01%	1219
2022 Q3	$84.1K	Hold	5,096	–	–	﹤0.01%	1120
2022 Q2	$107K	Hold	5,096	–	–	﹤0.01%	1018
2022 Q1	$120K	Sell	5,096 -15,170	-75%	-$371K	﹤0.01%	1084
2021 Q4	$551K	Hold	20,266	–	–	0.01%	1364
2021 Q3	$576K	Sell	20,266 -2,150	-10%	-$65.5K	0.01%	1364
2021 Q2	$676K	Buy	22,416 +1,127	+5%	+$33.3K	0.01%	1309
2021 Q1	$542K	Sell	21,289 -697	-3%	-$17.9K	0.01%	1361
2020 Q4	$540K	Sell	21,986 -14,019	-39%	-$263K	0.01%	1308
2020 Q3	$586K	Sell	36,005 -4,496	-11%	-$83.6K	0.01%	1103
2020 Q2	$693K	Buy	40,501 +18,116	+81%	+$269K	0.01%	983
2020 Q1	$261K	Sell	22,385 -1,219	-5%	-$25.1K	0.01%	1433
2019 Q4	$656K	Buy	23,604 +165	+0.7%	+$4.14K	0.01%	1167
2019 Q3	$530K	Sell	23,439 -1,323	-5%	-$30.2K	0.01%	1251
2019 Q2	$625K	Sell	24,762 -356	-1%	-$9.56K	0.01%	1164
2019 Q1	$682K	Sell	25,118 -433	-2%	-$14.5K	0.01%	1106
2018 Q4	$843K	Sell	25,551 -1,073	-4%	-$43.1K	0.02%	899
2018 Q3	$1.24M	Sell	26,624 -571	-2%	-$26.2K	0.02%	809
2018 Q2	$1.18M	Buy	27,195 +202	+0.7%	+$9.68K	0.02%	836
2018 Q1	$1.5M	Buy	26,993 +236	+0.9%	+$12.9K	0.02%	701
2017 Q4	$1.43M	Sell	26,757 -61,201	-70%	-$2.89M	0.02%	730
2017 Q3	$3.79M	Buy	87,958 +460	+0.5%	+$21.9K	0.02%	720
2017 Q2	$5.28M	Sell	87,498 -2,431	-3%	-$144K	0.04%	539
2017 Q1	$6.24M	Buy	89,929 +832	+0.9%	+$57.8K	0.04%	454
2016 Q4	$5.94M	Buy	89,097 +69	+0.1%	+$4.49K	0.04%	454
2016 Q3	$5.9M	Sell	89,028 -1,251	-1%	-$85.6K	0.04%	442
2016 Q2	$6.54M	Buy	90,279 +2,802	+3%	+$193K	0.05%	389
2016 Q1	$5.65M	Buy	87,477 +2,200	+3%	+$146K	0.04%	451
2015 Q4	$6.11M	Buy	85,277 +416	+0.5%	+$30.8K	0.05%	406
2015 Q3	$6.52M	Sell	84,861 -251	-0.3%	-$20.3K	0.05%	374
2015 Q2	$6.31M	Sell	85,112 -2,357	-3%	-$170K	0.04%	428
2015 Q1	$6.34M	Sell	87,469 -622	-0.7%	-$43.2K	0.05%	415
2014 Q4	$5.82M	Buy	88,091 +1,007	+1%	+$61.5K	0.04%	456
2014 Q3	$4.77M	Buy	87,084 +1,250	+1%	+$70.9K	0.03%	527
2014 Q2	$4.99M	Sell	85,834 -1,259	-1%	-$74.1K	0.03%	541
2014 Q1	$5.4M	Buy	87,093 +2,093	+2%	+$122K	0.04%	495
2013 Q4	$4.54M	Sell	85,000 -192	-0.2%	-$10.3K	0.03%	565
2013 Q3	$4.28M	Buy	85,192 +1,936	+2%	+$94.5K	0.03%	553
2013 Q2	$3.81M	Buy	+83,256	New	+$3.73M	0.03%	567

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s MD Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Pediatrix Medical (MD) in Q2 2024, closing a stake of 4,982 shares — an estimated $50K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in MD in Q2 2013 and held it in 44 quarters. The position peaked at $6.54M in Q2 2016. 227 funds tracked by Wall St. Rank hold MD as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Pediatrix Medical position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 4,982 Pediatrix Medical shares in Q2 2024, an estimated $50K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Pediatrix Medical in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Pediatrix Medical position peaked at $6.54M in Q2 2016.
227 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.